Oncology projects currently take up about 40% of Pfizer’s overall R&D budget. | After steering positive key pivotal readouts for a trio of Novartis’ blockbusters, Jeff Legos is now tasked with ...

As geopolitical tensions, inflation, currency instability, and supply‑chain disruptions continue to escalate, global markets ...

Bindbridge’s breakthrough to designing new molecular glues – the foundation of tomorrow’s herbicides, insecticides, and fungicides - will help to boost global food security and reduce environmental ...

An international group of cancer experts has called for fundamental change to healthcare approaches for bile duct cancer, which kills three-quarters of patients within a year of diagnosis.

Arcus Biosciences beat FY25 EPS/revenue estimates as Casdatifan drives upside; $1.01B cash funds Phase 3 into 2H28. Click for my latest analysis of RCUS stock.

Neuroscience research has rapidly advanced our understanding of the molecular mechanisms underlying neurodevelopmental and neurodegenerative disorders.

Positive results from the aleniglipron Phase 2 ACCESS programs in December 2025 demonstrated significant weight loss across all doses and up to 15.3% at 36 weeks Topline 44-week data from the ACCESS ...

Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...

Chemistry World provides expert, independent science journalism for the global chemical science community. We are part of the ...

Discover the critical bioanalytical factors that influence radiopharmaceutical drug development, from assay design to ...

Bio-based polyhydroxyalkanoates (PHAs) are considered one of the most promising sustainable alternatives to fossil-derived plastics. Poly[(D-lactate)-co-(R)-3-hydroxybutyrate] (LAHB) is an ...

Co., Ltd. (Sanyou Bio), a biotech company powered by super-trillion-molecule libraries and AI-driven technologies, today ...